Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey

Abstract

These results highlight the wide heterogeneity in surgical approaches to the axilla after NAT. To standardize the guidelines, further data from clinical research are urgently needed, which underlines the importance of the ongoing AXSANA (EUBREAST-3) study.